GSW catches Tamiflu consumer work

Share this article:
Roche named GSW Worldwide agency of record for Tamiflu DTC work, following a multi-agency pitch involving FCB, Kaplan-Thaler Group, Digitas and Avenue A|Razorfish.

Under the agreement, the inVentiv agency will take the lead on all consumer advertising and promotion, including strategic planning, media planning and placement, and direct marketing.
The brand has not had a consumer agency of record for several years, though Y&R has performed some consumer work on the account on a project basis. Sudler & Hennessey handles professional advertising and promotion for the antiviral drug, and media planning and buying has been awarded to PHD.

Last month, George Abercrombie, CEO of Roche's Hoffman-LaRoche, said rather than relying on governments, companies should stockpile enough vaccines and drugs to protect at least a quarter of their workers from the avian flu. “Stockpiling is necessary,” said Abercrombie. “We can't flip a switch to produce massive amounts of Tamiflu during a pandemic.”

Tamiflu was co-developed by Roche and Gilead Sciences and is indicated for the treatment of uncomplicated influenza caused by virus types A and B, but has seen a boom of interest since emerging as a potential treatment for avian flu. In May, World Health Organization asked Roche to be ready to ship its stockpile of Tamiflu to Indonesia amid an avian flu outbreak there, and the WHO deployed its own 9,500-dose stockpile of the drug from to blunt the crisis.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in News

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.